Previous reports have provided an excellent starting point for larger prospective studies of the clinical utility of circulating tumor DNA (ctDNA) and demonstrate that ctDNA may be a useful research tool for drug development, and the study of intratumor heterogeneity and clonal evolution. As a biotechnology company standing at the forefront of the industry, Creative Biolabs is proficient in advanced technologies and the latest methods. We are confident in offering high-quality and comprehensive ctdna detection services.